Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study

Yuri Kawai1, Masahiro Hayakawa2, Taihei Tanaka3

  • 1Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.

Insights

The incidence of pulmonary hypertension (PH) in infants with bronchopulmonary dysplasia (BPD) was 4.2% to 6.9%. Oligohydramnios and sepsis were significant risk factors for PH in very low birthweight infants (VLBWIs).

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Pulmonary hypertension (PH) incidence in bronchopulmonary dysplasia (BPD) lacks regional data.
  • Investigating PH incidence in very low birthweight infants (VLBWIs) with BPD is crucial.

Purpose of the Study:

  • To determine the incidence of PH in VLBWIs with BPD in Aichi Prefecture, Japan.
  • To identify clinical factors associated with PH in VLBWIs with BPD.

Main Methods:

  • Retrospective observational cohort study of VLBWIs born in 2015 in Aichi Prefecture.
  • Defined BPD based on oxygen/respiratory support at 28 days (BPD28d) and 36 weeks postmenstrual age (BPD36w).
  • Assessed PH at 36 weeks' PMA (PH36w) and analyzed risk factors using univariate analysis (Mann-Whitney U, Fisher's exact test).

Main Results:

  • Analyzed 441 VLBWIs; 217 met BPD28d criteria, 131 met BPD36w criteria.
  • PH36w incidence was 4.2% (BPD28d) and 6.9% (BPD36w).
  • Oligohydramnios (RR 2.71) and sepsis (RR 3.62) were significantly associated with PH36w.

Conclusions:

  • PH36w incidence in VLBWIs with BPD was 4.2% (BPD28d) and 6.9% (BPD36w).
  • Oligohydramnios and sepsis are significant risk factors for PH36w in VLBWIs.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
273
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
284
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K